Beijing Hotgen Biotech Co., Ltd. (688068.SS) SHH

171.44

-8.08(-4.50%)

Updated at December 05 11:29AM

Currency In CNY

Valuation

Market Cap5.71B
Enterprise Value5.44B
P/E Ratio-61.5
PEG Ratio5.04
Price/Sales Ratio38.31
Price/Book Ratio5.44
Enterprise/Revenue38.17
Enterprise/EBITDA-135.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.6
Operating Margin-0.66

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue510.9M
Revenue/Share4.89
Gross Profit253.72M
EBITDA-69.84M
Net Income-191M
Diluted EPS-2.07

Balance Sheet

Total Cash789.88M
Total Cash/Share8.89
Total Debt59.71M
Total Debt/Equity0.02
Current Ratio5.07
Book Value Per Share32.98

Price History

52-Week Change238.72
52-Week High262.22
52-Week Low51.2
Moving Average 50 Days165.24
Moving Average 200 Days153.04

Statistics

Average Volume2.98M
Shares Outstanding92.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor37:25
Last Split DateJune 16, 2022